After TIM-4 treatment, TIM-1 was activated to increase the expression of Tip60, H3K9, RNA polymerase II significantly and, finally, activate STAT3 at the FasL promoter site, resulting in increased apoptosis frequency of colon cancer cells. Here, HAVCR1 is linked to colonic neoplasm.